Robert E. Bancroft serves as Executive at AEON Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Robert E. Bancroft has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 17, 2026 involved receiving (via award) 3,000,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | AEON | $0 | Award | 3,000,000 | $N/A | Discretionary |
Robert E. Bancroft currently holds 3,177,103 shares of AEON Biopharma, Inc. (AEON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert E. Bancroft has been a net neutral trader of AEON stock. They have purchased $0 and sold $0 worth of shares.
Robert E. Bancroft's most recent insider trade was on Feb 17, 2026, when they sold 3,000,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted